Inactivated Poliovirus Vaccine and Vaccine-Associated Paralytic Poliomyelitis-Reply

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 4, 1997, Pages 295-

  Sutter, Roland W ^a   Strebel, Peter M ^a   Miller, Mark A ^a   Hadler, Stephen C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

DRUG EFFECT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LETTER; ORAL DRUG ADMINISTRATION; PARALYSIS; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION;

EID: 0031031185     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540280033019     Document Type: Letter

References (5)

1. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States: one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14:568-579.
2. Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980-1991: implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994;148:479-485.
3. Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunologically abnormal persons. Infect Med. 1994;11:, 429-438.
4. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145-156.
5. Hara M, Saito Y, Komatsu T, et al. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiol Immunol. 1981;25:905-913.